Streetbeat News

Products Services

EZFL

EzFill Holdings, Inc. (NASDAQ:EZFL) reported a record 1.58 million gallons delivered in Q2 2023, a 20% increase from Q1 2023 and a 100% increase from Q2 2022. This is the sixth consecutive quarter of growth, attributed to the addition of 53 new fleet accounts and successful residential and marine marketing campaigns. The company also launched a condominium and homeowners association offering, which is expected to further boost growth.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 8:14 pm

BMY

PRTA

Bristol Myers Squibb has exercised its option to obtain exclusive worldwide commercial rights for PRX005, an anti-tau antibody developed by Prothena for the potential treatment of Alzheimer's disease. Bristol Myers Squibb will pay Prothena $55M and will be responsible for development, manufacturing, and commercialization of PRX005.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 8:12 pm

VSTO

Vista Outdoor Inc. (NYSE:VSTO) has appointed Jordan Judd as president of its brand Simms Fishing Products, effective Aug. 1. Judd previously served as president and general manager of Salomon North America, a brand owned by Amer Sports. Vista Outdoor acquired Simms in 2022, and the brand will be included in the new Outdoor Products Company upon completion of the previously announced separation.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 8:08 pm

VRDN

Viridian has announced data from its ongoing Phase 1/2 trial evaluating VRDN-001 in patients with chronic Thyroid Eye Disease (TED). The data showed clinically meaningful and rapid improvement in signs and symptoms of chronic TED at week 6 after receiving two infusions of VRDN-001. The company has amended its ongoing THRIVE Phase 3 trial based on this data and stakeholder feedback. Viridian also plans to select a lead subcutaneous (SC) program candidate by the end of 2023.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 8:03 pm

INMB

INmune Bio, Inc. (NASDAQ:INMB) has announced important findings from data presented at The 16th European Meeting on Glial Cells in Health and Disease. The data shows that XPro, a product of INmune Bio, promotes remyelination by affecting astroglial and microglial biology. This could potentially lead to effective treatments for many neurodegenerative diseases.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 8:01 pm

ICAD

iCAD is showcasing its ProFound AI Suite of solutions for breast cancer detection at the AHRA 2023 annual meeting. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 7:29 pm

AAPL

Apple Inc's shares are trading lower by 1.19% to $188.42, potentially due to investors awaiting Wednesday’s inflation report. The company has seen a year-to-date increase in its trading value of approximately 50.65%, attributed to interest in technology and AI-related stocks. Apple's integration of AI technology into its products and services could attract investors. The June CPI inflation report is anticipated as a significant economic event, with traders awaiting its release for insights into the Fed's future policy decisions.

Portfolio Pulse from Henry Khederian

July 10, 2023 | 7:06 pm

DUOL

KeyBanc Capital Markets analyst Justin Patterson reiterated a Sector Weight rating on Duolingo, Inc. (NASDAQ:DUOL), noting the company's shift towards gamification and away from the EdTech business. Duolingo's Daily Active Users (DAUs) are projected to double from 2021 to 2023, reaching 20 million by year-end. Duolingo leads in app downloads over rival language apps like Babbel. The recently launched Duolingo Max, leveraging GPT-4 from OpenAI, is expected to enhance the learning experience and potentially lift 2024 revenue projections by 1% for each 1% of subscribers that adopt it. However, the analyst is cautious about the rollout speed, additional features, and pricing changes of Max.

Portfolio Pulse from Nabaparna Bhattacharya

July 10, 2023 | 7:00 pm

SISI

Shineco Inc's subsidiary, Changzhou Biowin Pharmaceutical Co Ltd, has received marketing and distribution approval for its Cardiac 5-Minute Test from the Jiangsu Bureau of the National Medical Products Administration (NMPA). The test, which can detect three major cardiac markers, is the first and only product on the market in China to complete the detection process for cardiac markers within 5 minutes. Following the news, Shineco's shares are trading higher.

Portfolio Pulse from Vandana Singh

July 10, 2023 | 6:53 pm

MSFT

Microsoft Corp (MSFT) shares are trading lower by 1.9% to $330.82, potentially due to investors awaiting Wednesday’s inflation report. Despite this, Microsoft has seen a 38% increase in its stock on a year-to-date basis due to interest in AI-related stocks. The company has been actively investing in AI research, development, and acquisitions, which could drive higher demand for its AI-powered products and services, leading to revenue growth and improved financial performance.

Portfolio Pulse from Henry Khederian

July 10, 2023 | 6:29 pm